Stage IA Breast Cancer Completed Phase 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs